BIOFLUX SYSTEM USED IN KEY STUDIES TO IDENTIFY CAUSES AND TREATMENTS OF BLOOD CLOTS RELATED TO COVID-19
Potential treatments identified that may offer improved outcomes in COVID-19 patients with...
Potential treatments identified that may offer improved outcomes in COVID-19 patients with...
356-patient concordance study confirms performance using head-to-head testing vs. droplet digital...
All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration...
New panels target EGFR Pathways, clinically relevant myeloid genes, and TP53Alameda, CA, December...
Patented ERASE-Seq approach delivers ultra-high sensitivity somatic mutation detection using...
Grant will support development of Spotlight™ NIPT, a novel single-cell NGS assay for non-invasive...
Our CTO, Dr. Cristian Ionescu-Zanetti, presented this webinar on Thursday, August 1. The webinar...
Participation will help advance liquid biopsy adoption by collaborating among key industry...
Glycocalyx research utilizing the BioFlux System
Publications demonstrate depth and breadth of Fluxion’s liquid biopsy technologies